Department of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
BMC Musculoskelet Disord. 2010 May 28;11:104. doi: 10.1186/1471-2474-11-104.
Numerous transcription factors are involved in the establishment and maintenance of the osteoblastic phenotype, such as Runx2, osterix and Dlx5. The transcription factor retinoblastoma binding protein-1 (RBP1) was recently identified as an estrogen regulated gene in an osteosarcoma cell model. Since the function of RBP1 in osteoblastic differentiation and mineralization is unknown, we investigated the role of RBP1 in these processes.
To create a cell model with suppressed RBP1 expression, primary calvarial osteoblasts were infected with a shRNA lentiviral vector specific for mouse RBP1 (CalOB-DeltaRBP1) or a scrambled control shRNA lentivirus (CalOB-Control). Stable cell lines were generated and their mineralization potential was determined using osteoblastic differentiation medium, Alizarin Red staining, and quantitative PCR (QPCR) analyses. Runx2 coactivation by RBP1 was determined through the use of transient transfection assays.
Stable expression of the RBP1 shRNA lentivirus in CalOB-DeltaRBP1 cells resulted in a 65-70% suppression of RBP1 expression. Osteoblastic mineralization assays demonstrated that suppression of RBP1 results in a potent delay in osteoblastic nodule formation in the CalOB-DeltaRBP1 cells with a concomitant decrease in the expression of the osteogenic transcription factors Runx2 and osterix, along with decreases in BMP2, alkaline phosphatase, osteocalcin and bone sialoprotein. Regulation of Runx2 expression by RBP1 was shown to be mediated through the proximal P2 Runx2 promoter. Furthermore, RBP1 was demonstrated to be a potent coactivator of Runx2 transcriptional activity on two known Runx2 reporter constructs. These data suggest that the expression and activity of Runx2 is critically dependent on the presence of RBP1.
This study is the first to demonstrate that RBP1 is an important mediator of the osteoblastic phenotype and clearly defines RBP1 as a novel transcription factor involved in the well known Runx2-osterix transcriptional cascade. As such, the effects of RBP1 on these processes are mediated through both regulation of Runx2 expression and transcriptional activity.
许多转录因子参与成骨细胞表型的建立和维持,如 Runx2、osterix 和 Dlx5。转录因子视网膜母细胞瘤结合蛋白 1(RBP1)最近在骨肉瘤细胞模型中被鉴定为受雌激素调控的基因。由于 RBP1 在成骨细胞分化和矿化中的功能尚不清楚,因此我们研究了 RBP1 在这些过程中的作用。
为了创建一个 RBP1 表达受抑制的细胞模型,原代颅骨成骨细胞被特异性针对小鼠 RBP1 的 shRNA 慢病毒载体(CalOB-DeltaRBP1)或乱序对照 shRNA 慢病毒(CalOB-Control)感染。生成稳定细胞系,并使用成骨细胞分化培养基、茜素红染色和定量 PCR(QPCR)分析来确定它们的矿化潜能。通过瞬时转染测定来确定 RBP1 对 Runx2 的共激活作用。
CalOB-DeltaRBP1 细胞中 RBP1 shRNA 慢病毒的稳定表达导致 RBP1 表达抑制 65-70%。成骨矿化测定表明,RBP1 的抑制导致 CalOB-DeltaRBP1 细胞中成骨结节形成的明显延迟,同时降低了成骨转录因子 Runx2 和 osterix 的表达,以及 BMP2、碱性磷酸酶、骨钙素和骨涎蛋白的表达。表明 RBP1 对 Runx2 表达的调节是通过近端 P2 Runx2 启动子介导的。此外,RBP1 被证明是两个已知 Runx2 报告基因构建体的 Runx2 转录活性的有效共激活因子。这些数据表明,Runx2 的表达和活性严重依赖于 RBP1 的存在。
这项研究首次表明,RBP1 是成骨细胞表型的重要介质,并明确将 RBP1 定义为参与众所周知的 Runx2-osterix 转录级联的新型转录因子。因此,RBP1 对这些过程的影响是通过调节 Runx2 的表达和转录活性来介导的。